Target intelligence / Profile preview

RNA, U6 small nuclear 326, pseudogene (RNU6-326P)

Target
RNU6-326P
Molecular classification
Pseudogene, Non-coding RNA (if transcribed), snRNA-derived pseudogene
01

Overview

RNU6-326P (RNA, U6 small nuclear 326, pseudogene) is a processed pseudogene locus found in the human genome, deriving from a genomic duplication of the highly conserved U6 small nuclear RNA gene[2][3]. The functional U6 snRNA is an essential component of the spliceosome, responsible for intron removal from precursor mRNA during post-transcriptional modification in the nucleus[3]. Pseudogenes like RNU6-326P are typically non-coding and do not produce functional RNA or protein products. While some pseudogenes have been shown to participate in limited regulatory functions, such as competitive endogenous RNA mechanisms, there is no evidence for such activity from RNU6-326P specifically[4][6]. It is not considered a therapeutic target, does not interact with drugs, and is not used as a biomarker. Its presence in the genome reflects the evolutionary importance of U6 snRNA, but as a pseudogene, RNU6-326P is presumed biologically inert. If you require information about the *functional U6 snRNA* as a drug target, that would be a distinct entry, as the pseudogene itself does not have therapeutic relevance[2][3].

Other names
RNU6-326PRNA, U6 small nuclear 326, pseudogene
02

Biological functions

Other (potentially none; pseudogenes are generally considered non-functional, but some may have limited regulatory roles as competitive endogenous RNAs or lncRNAs[4][6])Possible roles in transcriptional regulation, if expressed
03

Disease associations

Other (no direct disease association reported for RNU6-326P specifically; rare evidence exists for pseudogene involvement in regulation affecting cancer or other diseases, but not for this locus[4][6])

Beyond the preview

Go deeper on RNA, U6 small nuclear 326, pseudogene (RNU6-326P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 326, pseudogene (RNU6-326P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call